Back to Results

EFTA02454617.pdf

Source: DOJ_DS11  •  Size: 98.1 KB  •  OCR Confidence: 85.0%
PDF Source (No Download)

Extracted Text (OCR)

From: Ens, Amanda <amanda.ens@baml.com> Sent: Monday, August 8, 2016 6:42 PM To: jeevacation@gmail.com Subject: Physician Dinner with Dr. Yaacov Anziska in NY 8/15 Jeffrey, let me know if you're interested and I'll try to get a slot. BofAML biotech analyst Ying Huang is hosting a Physician Dinner with Dr. Yaacov Anziska, M.D, M.S. Assistant Professor in the department of Neurology at SUNY-Downstate Medical Center Program on Monday, August 15th in New York. Purpose: To discuss treatment of spinal muscular atrophy (SMA). We will discuss latest developments in treatment of SMA with a particular focus on BIIB's Phase 3 trials of nusinersen and the market opportunity for treatment of SMA infants and children. Host: Ying Huang Sector Specialist: Dan Lundquist Corporate Access: Caroline Goodson Time/Location: 7PM/Midtown location TBA Format: Group Dinner Bio: Yaacov Anziska, M.D, M.S. is Assistant Professor in the department of Neurology at SUNY-Downstate Medical Center. He directs the Muscular Dystrophy Association (MDA) Neuromuscular Clinic and also serves as the Assistant Residency Director in Neurology. Dr. Anziska also has a strong interest in bringing new drugs and treatments from the lab into clinical practice, as well as pursuing the latest genetic testing available in neuromuscular disease. Dr. Anziska treats 12- 15 SMA patients per month and is familiar treatments for SMA in Type 1, 2, and 3 patients including nusinersen. EFTA_R1_01556470 EFTA02454617 Amanda Ens Director Bank of America Merrill Lynch Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park, 5th Floor, New York, NY 10036 The power of global connections" This message, and any attachments, is for the intended recipient(s) only, may contain information that is privileged, confidential and/or proprietary and subject to important terms and conditions available at http://www.bankofamerica.com/emaildisclaimer. If you are not the intended recipient, please delete this message. 2 EFTA_R1_01556471 EFTA02454618

Document Preview

PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.

Document Details

Filename EFTA02454617.pdf
File Size 98.1 KB
OCR Confidence 85.0%
Has Readable Text Yes
Text Length 2,050 characters
Indexed 2026-02-12T17:30:45.517721
Ask the Files